177 related articles for article (PubMed ID: 25850769)
1. Selection of Potential Pharmacological Targets in ALS Based on Whole- Genome Expression Profiling.
Morello G; Conforti FL; Parenti R; D'Agata V; Cavallaro S
Curr Med Chem; 2015; 22(17):2004-21. PubMed ID: 25850769
[TBL] [Abstract][Full Text] [Related]
2. Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis.
Lederer CW; Torrisi A; Pantelidou M; Santama N; Cavallaro S
BMC Genomics; 2007 Jan; 8():26. PubMed ID: 17244347
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional analysis reveals distinct subtypes in amyotrophic lateral sclerosis: implications for personalized therapy.
Morello G; Cavallaro S
Future Med Chem; 2015; 7(10):1335-59. PubMed ID: 26144267
[TBL] [Abstract][Full Text] [Related]
4. Neuroinflammation and ALS: Transcriptomic Insights into Molecular Disease Mechanisms and Therapeutic Targets.
Morello G; Spampinato AG; Cavallaro S
Mediators Inflamm; 2017; 2017():7070469. PubMed ID: 29081603
[TBL] [Abstract][Full Text] [Related]
5. Selection and Prioritization of Candidate Drug Targets for Amyotrophic Lateral Sclerosis Through a Meta-Analysis Approach.
Morello G; Spampinato AG; Conforti FL; D'Agata V; Cavallaro S
J Mol Neurosci; 2017 Apr; 61(4):563-580. PubMed ID: 28236105
[TBL] [Abstract][Full Text] [Related]
6. Integrative multi-omic analysis identifies new drivers and pathways in molecularly distinct subtypes of ALS.
Morello G; Guarnaccia M; Spampinato AG; Salomone S; D'Agata V; Conforti FL; Aronica E; Cavallaro S
Sci Rep; 2019 Jul; 9(1):9968. PubMed ID: 31292500
[TBL] [Abstract][Full Text] [Related]
7. A computational biology approach to identify potential protein biomarkers and drug targets for sporadic amyotrophic lateral sclerosis.
Kumar R; Malik MZ; Thanaraj TA; Bagabir SA; Haque S; Tambuwala M; Haider S
Cell Signal; 2023 Dec; 112():110915. PubMed ID: 37838312
[TBL] [Abstract][Full Text] [Related]
8. Advances and challenges in understanding the multifaceted pathogenesis of amyotrophic lateral sclerosis.
Laferriere F; Polymenidou M
Swiss Med Wkly; 2015; 145():w14054. PubMed ID: 25635517
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis of ALS and FTD: implications for translational studies.
Liščić RM
Arh Hig Rada Toksikol; 2015 Dec; 66(4):285-90. PubMed ID: 26751860
[TBL] [Abstract][Full Text] [Related]
10. Molecular classification of amyotrophic lateral sclerosis by unsupervised clustering of gene expression in motor cortex.
Aronica E; Baas F; Iyer A; ten Asbroek AL; Morello G; Cavallaro S
Neurobiol Dis; 2015 Feb; 74():359-76. PubMed ID: 25500340
[TBL] [Abstract][Full Text] [Related]
11. New insights into the gene expression associated to amyotrophic lateral sclerosis.
Recabarren-Leiva D; Alarcón M
Life Sci; 2018 Jan; 193():110-123. PubMed ID: 29241710
[TBL] [Abstract][Full Text] [Related]
12. Identification of epigenetically altered genes in sporadic amyotrophic lateral sclerosis.
Figueroa-Romero C; Hur J; Bender DE; Delaney CE; Cataldo MD; Smith AL; Yung R; Ruden DM; Callaghan BC; Feldman EL
PLoS One; 2012; 7(12):e52672. PubMed ID: 23300739
[TBL] [Abstract][Full Text] [Related]
13. Molecular Taxonomy of Sporadic Amyotrophic Lateral Sclerosis Using Disease-Associated Genes.
Morello G; Spampinato AG; Cavallaro S
Front Neurol; 2017; 8():152. PubMed ID: 28469596
[TBL] [Abstract][Full Text] [Related]
14. Microarray analysis of peripheral blood lymphocytes from ALS patients and the SAFE detection of the KEGG ALS pathway.
Mougeot JL; Li Z; Price AE; Wright FA; Brooks BR
BMC Med Genomics; 2011 Oct; 4():74. PubMed ID: 22027401
[TBL] [Abstract][Full Text] [Related]
15. [Molecular pathogenesis of motor neuron disease].
Sobue G
Rinsho Shinkeigaku; 2001 Dec; 41(12):1070-1. PubMed ID: 12235798
[TBL] [Abstract][Full Text] [Related]
16. Suppression of adenosine 2a receptor (A2aR)-mediated adenosine signaling improves disease phenotypes in a mouse model of amyotrophic lateral sclerosis.
Ng SK; Higashimori H; Tolman M; Yang Y
Exp Neurol; 2015 May; 267():115-22. PubMed ID: 25779930
[TBL] [Abstract][Full Text] [Related]
17. An Integrative Transcriptome-Wide Analysis of Amyotrophic Lateral Sclerosis for the Identification of Potential Genetic Markers and Drug Candidates.
Park S; Kim D; Song J; Joo JWJ
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809961
[TBL] [Abstract][Full Text] [Related]
18. Genomic variants in the FTO gene are associated with sporadic amyotrophic lateral sclerosis in Greek patients.
Mitropoulos K; Merkouri Papadima E; Xiromerisiou G; Balasopoulou A; Charalampidou K; Galani V; Zafeiri KV; Dardiotis E; Ralli S; Deretzi G; John A; Kydonopoulou K; Papadopoulou E; di Pardo A; Akcimen F; Loizedda A; Dobričić V; Novaković I; Kostić VS; Mizzi C; Peters BA; Basak N; Orrù S; Kiskinis E; Cooper DN; Gerou S; Drmanac R; Bartsakoulia M; Tsermpini EE; Hadjigeorgiou GM; Ali BR; Katsila T; Patrinos GP
Hum Genomics; 2017 Dec; 11(1):30. PubMed ID: 29216901
[TBL] [Abstract][Full Text] [Related]
19. Whole-genome association studies of sporadic amyotrophic lateral sclerosis: are retroelements involved?
Mougeot JL; Richardson-Milazi S; Brooks BR
Trends Mol Med; 2009 Apr; 15(4):148-58. PubMed ID: 19332388
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profiling toward understanding of ALS pathogenesis.
Tanaka F; Niwa J; Ishigaki S; Katsuno M; Waza M; Yamamoto M; Doyu M; Sobue G
Ann N Y Acad Sci; 2006 Nov; 1086():1-10. PubMed ID: 17185501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
